Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391:2547–2559

Article  PubMed  Google Scholar 

Hasegawa S, Yoneda M, Kurita Y, Nogami A, Honda Y, Hosono K, et al. Cholestatic liver disease: current treatment strategies and new therapeutic agents. Drugs. 2021;81:1181–1192

Article  CAS  PubMed  PubMed Central  Google Scholar 

Visseren T, Erler NS, Polak WG, Adam R, Karam V, Vondran FWR, et al. Recurrence of primary sclerosing cholangitis after liver transplantation—analysing the European Liver Transplant Registry and beyond. Transpl Int. 2021;34:1455–1467

Article  PubMed  Google Scholar 

Melum E, Franke A, Schramm C, Weismüller TJ, Gotthardt DN, Offner FA, et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet. 2011;43:17–19

Article  CAS  PubMed  Google Scholar 

Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49:269–273

Article  CAS  PubMed  Google Scholar 

Burgess S, Mason AM, Grant AJ, Slob EAW, Gkatzionis A, Zuber V, et al. Using genetic association data to guide drug discovery and development: review of methods and applications. Am J Hum Genet. 2023;110:195–214

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang H, Chen L, Liu Y. A large-scale plasma proteome Mendelian randomization study identifies novel causal plasma proteins related to primary biliary cholangitis. Front Immunol. 2023;14:1052616

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Xu F, Ruan X, Sun J, Zhang Y, Zhang H, et al. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses. EBioMedicine. 2023;89: 104494

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53:1712–1721

Article  CAS  PubMed  Google Scholar 

Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481–487

Article  CAS  PubMed  Google Scholar 

Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10: e1004383

Article  PubMed  PubMed Central  Google Scholar 

Pazoki R, Vujkovic M, Elliott J, Evangelou E, Gill D, Ghanbari M, et al. Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes. Nat Commun. 2021;12:2579

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han Y, Byun J, Zhu C, Sun R, Roh JY, Cordell HJ, et al. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis. Nat Commun. 2023;14:1069

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turley P, Walters RK, Maghzian O, Okbay A, Lee JJ, Fontana MA, et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat Genet. 2018;50:229–237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Julià A, Domènech E, Ricart E, Tortosa R, García-Sánchez V, Gisbert JP, et al. A genome-wide association study on a southern European population identifies a new Crohn’s disease susceptibility locus at RBX1-EP300. Gut. 2013;62:1440–1445

Article  PubMed  Google Scholar 

Román ID, Cano-Martínez D, Lobo MV, Fernández-Moreno MD, Hernández-Breijo B, Sacristán S, et al. Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease. Biomarkers. 2017;22:133–144

Article  PubMed  Google Scholar 

Elizondo DM, Brandy NZ, da Silva RL, de Moura TR, Lipscomb MW. Allograft inflammatory factor-1 in myeloid cells drives autoimmunity in type 1 diabetes. JCI Insight. 2020;5(10):e136092

Chinnasamy P, Lutz SE, Riascos-Bernal DF, Jeganathan V, Casimiro I, Brosnan CF, et al. Loss of allograft inflammatory factor-1 ameliorates experimental autoimmune encephalomyelitis by limiting encephalitogenic CD4 T-cell expansion. Mol Med. 2015;21:233–241

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peres DS, Theisen MC, Fialho MFP, Dalenogare DP, Rodrigues P, Kudsi SQ, et al. TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice. Brain Res Bull. 2021;175:1–15

Article  CAS  PubMed  Google Scholar 

Churchill MJ, Cantu MA, Kasanga EA, Moore C, Salvatore MF, Meshul CK. Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson’s disease. Neuroscience. 2019;414:8–27

Article  CAS  PubMed  Google Scholar 

Cao F, Souders Ii CL, Perez-Rodriguez V, Martyniuk CJ. Elucidating conserved transcriptional networks underlying pesticide exposure and Parkinson’s disease: a focus on chemicals of epidemiological relevance. Front Genet. 2018;9:701

Article  CAS  PubMed  Google Scholar 

Tong M, Dong M, de la Monte SM. Brain insulin-like growth factor and neurotrophin resistance in Parkinson’s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis. 2009;16:585–599

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet. 2013;45:670–675

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong SN, Park C, Park SJ, Lee CK, Ye BD, Kim YS, et al. Deep resequencing of 131 Crohn’s disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants. Gut. 2016;65:788–796

Article  CAS  PubMed  Google Scholar 

Alarcón-Riquelme ME, Ziegler JT, Molineros J, Howard TD, Moreno-Estrada A, Sánchez-Rodríguez E, et al. Genome-wide association study in an amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of european admixture. Arthritis Rheumatol. 2016;68:932–943

Article  PubMed  PubMed Central  Google Scholar 

Schutt C, Mirizio E, Salgado C, Reyes-Mugica M, Wang X, Chen W, et al. Transcriptomic evaluation of juvenile localized scleroderma skin with histologic and clinical correlation. Arthritis Rheumatol. 2021;73:1921–1930

Article  CAS  PubMed  Google Scholar 

Wang M, Wu J, Lei S, Mo X. Genome-wide identification of RNA modification-related single nucleotide polymorphisms associated with rheumatoid arthritis. BMC Genomics. 2023;24:153

Article  PubMed  PubMed Central  Google Scholar 

Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357:851–862

Article  CAS  PubMed  Google Scholar 

Punia S, Juran BD, Ali AH, Schlicht EM, Moore RM, Sun Z, et al. Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers. BMC Gastroenterol. 2021;21:149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponnuraj EM, Hayward AR. Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. Clin Exp Immunol. 2002;128:416–420

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hedl M, Lahiri A, Ning K, Cho JH, Abraham C. Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn’s disease ICOSLG risk allele. Immunity. 2014;40:734–746

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arthur B, Fouad L (2023) Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies. eGastroenterology 1:e100010

Coulthard MG, Morgan M, Woodruff TM, Arumugam TV, Taylor SM, Carpenter TC, et al. Eph/Ephrin signaling in injury and inflammation. Am J Pathol. 2012;181:1493–1503

Article  CAS  PubMed  Google Scholar 

Can G, Ayvaz S, Can H, Demirtas S, Aksit H, Yilmaz B, et al. The Syk inhibitor fostamatinib decreases the severity of colonic mucosal damage in a rodent model of colitis. J Crohns Colitis. 2015;9:907–917

Article  PubMed  Google Scholar 

Zhang Y, Brenner M, Yang WL, Wang P. Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice. Lab Invest. 2015;95:480–490

Article  CAS  PubMed